Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity

被引:131
作者
Murga, M
Fernández-Capetillo, O
Field, SJ
Moreno, B
Borlado, LR
Fujiwara, Y
Balomenos, D
Vicario, A
Carrera, AC
Orkin, SH
Greenberg, ME
Zubiaga, AM [1 ]
机构
[1] Univ Basque Country, Fac Sci, Dept Anim Biol & Genet, E-48080 Bilbao, Spain
[2] Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA
[4] Basque Inst Agr Res & Dev, NEIKER, E-48160 Derio, Spain
[5] Univ Autonoma Madrid, Ctr Nacl Biotecnol, CSIC, Dept Immunol & Oncol, E-28049 Madrid, Spain
[6] Childrens Hosp, Howard Hughes Med Inst, Div Hematol Oncol, Boston, MA 02115 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1016/S1074-7613(01)00254-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
E2Fs are important regulators of proliferation, differentiation, and apoptosis. Here we characterize the phenotype of mice deficient in E2F2. We show that E2F2 is required for immunologic self-tolerance. E2F2(-/-) mice develop late-onset autoimmune features, characterized by widespread inflammatory infiltrates, glomerular immunocomplex deposition, and anti-nuclear antibodies. E2F2-deficient T lymphocytes exhibit enhanced TCR-stimulated proliferation and a lower activation threshold, leading to the accumulation of a population of autoreactive effector/memory T lymphocytes, which appear to be responsible for causing autoimmunity in E2F2-deficient mice. Finally, we provide support for a model to explain E2F2's unexpected role as a suppressor of T lymphocyte proliferation. Rather than functioning as a transcriptional activator, E2F2 appears to function as a transcriptional repressor of genes required for normal S phase entry, particularly E2F1.
引用
收藏
页码:959 / 970
页数:12
相关论文
共 49 条
[1]   Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice [J].
Amakawa, R ;
Hakem, A ;
Kundig, TM ;
Matsuyama, T ;
Simard, JJL ;
Timms, E ;
Wakeham, A ;
Mittruecker, HW ;
Griesser, H ;
Takimoto, H ;
Schmits, R ;
Shahinian, A ;
Ohashi, PS ;
Penninger, JM ;
Mak, TW .
CELL, 1996, 84 (04) :551-562
[2]   The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development [J].
Balomenos, D ;
Martín-Caballero, J ;
García, MI ;
Prieto, I ;
Flores, JM ;
Serrano, M ;
Martínez, C .
NATURE MEDICINE, 2000, 6 (02) :171-176
[3]  
Borlado LR, 2000, FASEB J, V14, P895
[4]   Retinoblastoma protein meets chromatin [J].
Brehm, A ;
Kouzarides, T .
TRENDS IN BIOCHEMICAL SCIENCES, 1999, 24 (04) :142-145
[5]   Distinct roles for E2F proteins in cell growth control and apoptosis [J].
DeGregori, J ;
Leone, G ;
Miron, A ;
Jakoi, L ;
Nevins, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7245-7250
[6]  
DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215
[7]   Impaired Fas response and autoimmunity in Pten+/- mice [J].
Di Cristofano, A ;
Kotsi, P ;
Peng, YF ;
Cordon-Cardo, C ;
Elkon, KB ;
Pandolfi, PP .
SCIENCE, 1999, 285 (5436) :2122-2125
[8]   The regulation of E2F by pRB-family proteins [J].
Dyson, N .
GENES & DEVELOPMENT, 1998, 12 (15) :2245-2262
[9]   E2F-1 functions in mice to promote apoptosis and suppress proliferation [J].
Field, SJ ;
Tsai, FY ;
Kuo, F ;
Zubiaga, AM ;
Kaelin, WG ;
Livingston, DM ;
Orkin, SH ;
Greenberg, ME .
CELL, 1996, 85 (04) :549-561
[10]   A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families [J].
Gaffney, PM ;
Kearns, GM ;
Shark, KB ;
Ortmann, WA ;
Selby, SA ;
Malmgren, ML ;
Rohlf, KE ;
Ockenden, TC ;
Messner, RP ;
King, RA ;
Rich, SS ;
Behrens, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14875-14879